These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21733981)

  • 1. The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.
    Pullen N; Birch CL; Douglas GJ; Hussain Q; Pruimboom-Brees I; Walley RJ
    Hum Reprod Update; 2011; 17(6):791-802. PubMed ID: 21733981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models in endometriosis research.
    Grümmer R
    Hum Reprod Update; 2006; 12(5):641-9. PubMed ID: 16775193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis.
    Laschke MW; Menger MD
    Hum Reprod Update; 2007; 13(4):331-42. PubMed ID: 17347159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
    Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
    J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endometriosis: from research to clinical practice].
    Nisolle M; Alvarez ML; Colombo M; Foidart JM
    Bull Mem Acad R Med Belg; 2007; 162(5-6):263-72; discussion 273-4. PubMed ID: 18404996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.
    Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS
    Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.
    Harris HA; Bruner-Tran KL; Zhang X; Osteen KG; Lyttle CR
    Hum Reprod; 2005 Apr; 20(4):936-41. PubMed ID: 15618247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhuman primate models for translational research in endometriosis.
    D'Hooghe TM; Kyama CM; Chai D; Fassbender A; Vodolazkaia A; Bokor A; Mwenda JM
    Reprod Sci; 2009 Feb; 16(2):152-61. PubMed ID: 19208783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis?
    D'Hooghe TM
    Curr Opin Obstet Gynecol; 2003 Jun; 15(3):243-9. PubMed ID: 12858113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
    Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
    Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment for rectovaginal endometriosis: what is the evidence?
    Vercellini P; Crosignani PG; Somigliana E; Berlanda N; Barbara G; Fedele L
    Hum Reprod; 2009 Oct; 24(10):2504-14. PubMed ID: 19574277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
    Verma A; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):112-5. PubMed ID: 19233536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder.
    Simitsidellis I; Gibson DA; Saunders PTK
    Best Pract Res Clin Endocrinol Metab; 2018 Jun; 32(3):257-269. PubMed ID: 29779580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis and the role of reproductive medicine.
    Bukulmez O
    Minerva Ginecol; 2009 Aug; 61(4):299-318. PubMed ID: 19745796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometriosis research: animal models for the study of a complex disease.
    Tirado-González I; Barrientos G; Tariverdian N; Arck PC; García MG; Klapp BF; Blois SM
    J Reprod Immunol; 2010 Nov; 86(2):141-7. PubMed ID: 20594597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives in the medical treatment of endometriosis.
    Ferrero S; Abbamonte LH; Anserini P; Remorgida V; Ragni N
    Obstet Gynecol Surv; 2005 Dec; 60(12):817-26. PubMed ID: 16359564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
    Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
    Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.